ID
19760
Beschreibung
The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS. Documentation process: This form is to be obtained in Screening.
Stichworte
Versionen (1)
- 27.01.17 27.01.17 -
Hochgeladen am
27. Januar 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM
Beschreibung
If 'Yes' record each detail below. If a category has multiple details, record each on a separate line. Mark if resolved or current.
Beschreibung
Line
Datentyp
integer
Alias
- UMLS CUI [1]
- C0750480
Beschreibung
Category Number
Datentyp
text
Alias
- UMLS CUI [1]
- C0683312
Beschreibung
resolved or current
Datentyp
integer
Beschreibung
details
Datentyp
text
Alias
- UMLS CUI [1]
- C1522508
Ähnliche Modelle
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM